US20110046452A1 - Wireless device and system for monitoring physiologic parameters - Google Patents

Wireless device and system for monitoring physiologic parameters Download PDF

Info

Publication number
US20110046452A1
US20110046452A1 US12/704,685 US70468510A US2011046452A1 US 20110046452 A1 US20110046452 A1 US 20110046452A1 US 70468510 A US70468510 A US 70468510A US 2011046452 A1 US2011046452 A1 US 2011046452A1
Authority
US
United States
Prior art keywords
implant
sensor
diseases
miniature
physiologic parameters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/704,685
Inventor
Nader Najafi
Sonbol Massoud-Ansari
Collin Anderson Rich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Integrated Sensing Systems Inc
Original Assignee
Integrated Sensing Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integrated Sensing Systems Inc filed Critical Integrated Sensing Systems Inc
Priority to US12/704,685 priority Critical patent/US20110046452A1/en
Assigned to INTEGRATED SENSING SYSTEMS, INC. reassignment INTEGRATED SENSING SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MASSOUD-ANSARI, SONBOL, NAJAFI, NADER, RICH, COLLIN ANDERSON
Publication of US20110046452A1 publication Critical patent/US20110046452A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/0215Measuring pressure in heart or blood vessels by means inserted into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6879Means for maintaining contact with the body
    • A61B5/6882Anchoring means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0204Operational features of power management
    • A61B2560/0214Operational features of power management of power generation or supply
    • A61B2560/0219Operational features of power management of power generation or supply of externally powered implanted units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37217Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • A61N1/37223Circuits for electromagnetic coupling

Definitions

  • This invention relates generally to medical devices monitoring blood pressure and other physiologic parameters.
  • a number of different physiologic parameters are strong candidates for continuous monitoring, such as blood pressure or flow, cardiovascular pressure, intracranial pressure, intraocular pressure, glucose levels, etc.
  • Wireless sensors in particular are highly desirable for biologic applications because the transcutaneous passage of wires (or other communication “tethers”) risks both infection to the patient and physical injury or device damage if the communication link experiences excessive pulling force.
  • a large number of proposed schemes for non-medical wireless communication rely on magnetic coupling between an electrical coil in an implanted device and a separate, external “readout” coil.
  • One method of wireless communication well-known to those knowledgeable in the art is that of the LC tank resonator.
  • a series-parallel connection of a capacitor and inductor has a specific resonant frequency ideally expressed as 1/ ⁇ square root over (LC) ⁇ , which can be measured from the impedance of the circuit. If one element of the inductor-capacitor pair varies with some physical parameter (e.g. pressure), while the other element remains at a known value, the physical parameter may be determined from the resonant frequency.
  • the capacitance may be back-calculated from the resonant frequency.
  • the sensed pressure may then be deduced from the capacitance by means of a calibrated pressure-capacitance transfer function.
  • the impedance of the LC tank may be measured directly or it may also be determined indirectly from the impedance of a separate readout coil that is magnetically coupled to the internal coil.
  • a separate readout coil that is magnetically coupled to the internal coil.
  • the latter case is most useful for biologic applications in that the sensing device may be subcutaneously implanted, while the readout coil may be located external to the body, but in a location that allows magnetic coupling between the implant and readout coil. It is possible for the readout coil (or coils) to simultaneously excite the implant resonator and sense the impedance reflected back to the readout coil. Consequently, this architecture has the substantial advantage of requiring no internal power source, which greatly improves its prospects for long-term implantation (e.g. decades to a human lifetime).
  • Frenkel U.S. Pat. No. 5,005,577 describes an implantable lens for monitoring intraocular pressure. Such a device would be advantageous for monitoring elevated eye pressures (as is usually the case for glaucoma patients); however, the requirement that the eye's crystalline lens be replaced will likely limit the general acceptance of this device.
  • CVF Chronic Heart Failure
  • Porat U.S. Pat. No. 6,277,078
  • Eigler U.S. Pat. No. 6,328,699
  • Carney U.S. Pat. No. 5,368,040
  • What is described is a general scheme of monitoring the heart. The existence of a method to construct a sensor with sufficient size, long-term fidelity, stability, telemetry range, and biocompatibility is noticeably absent in each case, being instead simply assumed.
  • the disclosed devices require a complex electromechanical assembly with many dissimilar materials, which will result in significant temperature- and aging-induced drift over time. Such assemblies may also be too large for many desirable applications, including intraocular pressure monitoring and/or pediatric applications. Finally, complex assembly processes will make such devices prohibitively expensive to manufacture for widespread use.
  • microfabricated sensors have also been proposed.
  • One such device is taught by Darrow (U.S. Pat. No. 6,201,980).
  • Others are reported in the literature (see, e.g. Park, et al., Jpn. J. Appl. Phys., 37 (1998), pp. 7124-7128; Puers, et al., J. Micromech. Microeng. 10 (2000), pp. 124-129; Harpster et al., Proc. 14 th IEEE Intl Conf. Microelectromech. Sys. (2001), pp. 553-557).
  • a self contained implantable sensing device consisting of a sensor, an electrical circuit for signal conditioning and magnetic telemetry, a biocompatible outer surface and seal, an anchoring method, and an external reader device.
  • the implant is small in size so that it may be delivered to the desired location and implanted using a catheter, although direct surgical implantation is also possible.
  • the circuit, sensor, and antenna for telemetry are packaged together in a small volume and sealed hermetically to the biologic environment.
  • the larger reader unit remains outside the body but proximal to the implant for minimizing communication distance.
  • FIG. 1 is a side view of a miniature sensor module according to a preferred embodiment of the present invention.
  • FIG. 2 is a top, side, and perspective view of a flexible substrate to rigid substrate self aligning connection illustrating a preferred arrangement of electrical leads within a substrate cavity.
  • FIG. 3 is a block diagram of a magnetic telemetry based physiologic monitoring system according to a preferred embodiment of the present invention.
  • FIG. 4 is a perspective view of a sensor implant incorporating a screw anchoring mechanism.
  • FIG. 5 is a side view of a sensor implanted in the atrial septum according to a preferred embodiment of the present invention.
  • the preferred communication scheme for the present invention is based on magnetic telemetry.
  • an implant 17 lays passive and without any internal means to power itself.
  • the reader 19 is brought into a suitable range to the implant 17 .
  • the reader 18 then creates an RF (Radio Frequency) magnetic field large enough to induce sufficient voltage across the implant coil 9 .
  • the implant circuit 8 may rectify the alternating waveform to create a direct voltage, which analog and/or digital circuitry may use as a power supply.
  • the implant 17 can be considered alert and, in the preferred embodiment, also ready for commands from the reader 18 .
  • a number of techniques may be used to convert the sensor output into a form suitable for transmission back to the reader 18 .
  • a capacitive pressure sensor 2 and sigma delta conversion or capacitance to frequency conversion of the sensor output may be easily used.
  • Capacitive sensors are preferred due to the small power requirements for electronics when reading capacitance values.
  • Many pressure sensors are based on piezoresistive effects and, while suitable for some applications, do suffer in this application due to the higher power levels needed for readout.
  • Sigma delta converters are preferred due to the tolerance of noisy supply voltages and manufacturing variations.
  • modulation schemes are available for transmitting data via magnetic coupling.
  • the preferred schemes include but are not limited to amplitude modulation, frequency modulation, frequency shift keying, phase shift keying, and also spread spectrum techniques.
  • the preferred modulation scheme may be determined by the specifications of an individual application, and is not intended to be limited under this invention.
  • the implant 17 may communicate back to the reader 18 the signal containing pressure information. It is understood that the reader 18 may transmit either a continuous level of RF power to supply the implant's needed energy, or it may pulse the power allowing temporary storage in a battery or capacitor device. Similarly, the implant 17 of FIG. 3 may signal back to the reader 18 at any interval in time, delayed or instantaneous, during reader RF transmission or alternately in the absence of reader transmission.
  • the implant 17 may include a single coil antenna 9 for both reception and transmission, or it may include two antennas, one each for transmission 21 and reception 9 .
  • the preferred embodiment of the invention is based on a small inner package, preferably of glass and silicon, that can be fit with a number of shell options for various implantation methods.
  • the cross-section in FIG. 1 illustrates a glass and silicon package for the miniature implant 17 according to a preferred embodiment of the invention.
  • the implant 17 includes a substrate 1 , a miniature sensor 2 , and electronics 3 (both coil 9 and integrated circuit die 8 included in electronics).
  • a secondary and optional substrate 4 may be used for attaching the various electronic components to each other and to sensor connections.
  • An alternative preferred method is to use a cylindrical shaped package, made from silicon, glass, ceramic, metal, plastic, or any combination thereof which houses the coil and the electronic components.
  • the miniature sensor 2 can either be fabricated separately and is attached to the cylindrical package or may be directly fabricated onto the substrate 1 .
  • the shell may be a separately fabricated piece into which the sensor 2 is placed; or it may be directly fabricated on the sensor submodule (or some portion thereof); or it may be integral to the inner package, being only defined by a change in material.
  • the purpose of the shell is to simplify fabrication by allowing different processes, process flows, materials, and/or structures to be used for the subassembly (e.g. MEMS technologies) and the shell (e.g. machining and/or molding of plastics, glass, metals, rubbers, polymers, etc.)
  • the material of the sensor submodule may be compatible with the environment, in which case a shell is not required and the submodule becomes the completed sensor.
  • the miniature sensor 2 can be any suitable miniature sensor adapted to detect and/or monitor various physiological parameters.
  • the sensor 2 can comprise a pressure sensor, a temperature sensor, a flow sensor, a velocity sensor, or a sensor adapted to measure specific chemistries such as gas content (e.g., O 2 and CO 2 ) and glucose levels.
  • gas content e.g., O 2 and CO 2
  • glucose levels e.g., glucose levels
  • chemistries e.g., O 2 and CO 2
  • Various specific examples of these types of miniature sensors are known to those skilled in the art, and any one or more of these suitable sensors can be utilized in the sensor module of the present invention. While the specific type of sensor(s) 2 chosen will depend on the application of the implantable system, the sensor(s) 2 should be of a sufficiently small size in order to facilitate placement within a catheter for delivery and implantation.
  • the bottom substrate 1 defines a cavity 6 in which the electronics 3 may be placed.
  • the rigid substrate cavity walls enclose the electronics 3 on five of the six possible sides.
  • at least part of the sensor 2 is disposed on the top side of the bottom substrate 1 .
  • Connections 16 to the sensor 2 may be made in a substrate recess 5 (recess is optional for increased clearance, and connection may alternately be co-planar with or above the plane of the substrate) adjoining the larger cavity 6 , or through alternate lead transfer techniques in the substrate cavity 6 .
  • a top substrate 7 is attached to the bottom substrate 1 to form a hermetic seal around the sensor and electronics.
  • the physically interacting parts of the sensor are formed in the top substrate 7 and complete the sensor structure after subsequent processing steps after bonding.
  • the two substrates 1 and 17 may be made of materials such as glass and silicon that are preferably anodically bonded together and provide excellent bond mechanical properties. Alternate methods of attachment include: fusion, frit, solder, laser welds, other welding, compression, thermal, thermal compression, eutectic, glue.
  • the electronic circuitry is connected together via a rigid or flexible substrate, which may be either the bottom substrate 1 or a separate substrate 4 .
  • the connection between the integrated circuit die 8 and substrate 1 or 4 is preferably made with flip-chip process to avoid the more fragile wire bonds.
  • the circuit die 8 may include ASIC (Application Specific Integrated Circuits), capacitors, or diodes.
  • the leads from the inductor coil 9 may fold over the substrate 4 or preformed for soldering to the substrate 4 with a preferably biocompatible solder such as gold-tin or silver-tin.
  • the flexible substrate 4 may also extend to the connections for the sensor 2 , where the connection may be made with a number of methods such as silver epoxy, laser welding, solder, or other.
  • FIG. 2 Aligning the flexible substrate 4 to the bottom substrate recess 5 is shown in FIG. 2 .
  • a preferred structure to accommodate manufacturing tolerances matches a tapered recess 5 in the bottom substrate 1 to a wedge fixture 15 of the flex circuit 4 , ensuring that electrical contacts 16 are properly aligned. As the wedge 15 is inserted into the recess 5 , the electrical contacts 16 are forced to align themselves to avoid faulty connections. Furthermore, any variance in the width of the wedges 15 and recess 5 will be accommodated by a small variation in the final, lateral depth of insertion of the flex circuit 4 .
  • FIG. 3 illustrates a block diagram for the electronics 3 according to the present invention.
  • the electronic circuit may consist of a receiving inductor coil 9 , rectification circuitry 10 , signal conditioning circuitry 11 , and signal transmission circuitry 12 .
  • the coil conductor may be wound around a ferrite core to enhance magnetic properties, deposited on a flat rigid or flexible substrate, and formed into a long/skinny or short/wide cylindrical solenoid.
  • the conductor is preferably made at least in part with a metal of high conductivity such as copper, silver, gold.
  • the coil may alternately be fabricated on substrates 1 , 4 , or 8 (or any combination thereof) of FIG. 1 . Methods of fabrication include sputtering, electroplating, lift-off, screen printing, and/or other suitable methods known to those skilled in the art.
  • the rectification circuitry 10 outputs a constant voltage level for the other electronics from an alternating voltage input. Efficient realizations of such circuitry are standard electronic techniques and may include full bridge diode rectifiers in the preferred embodiment. This rectification circuitry may include a capacitor for transient energy storage to reduce the noise ripple on the output supply voltage. This circuitry may be implemented on the same integrated circuit die with other electronics.
  • the signal conditioning circuit 11 processes an output signal from the sensor 2 and prepares it for transmission to an external receiving and/or analyzing device. For example, many pressure sensors output a capacitance signal that may be digitized for radio frequency (RF) transmission. Accordingly, the signal conditioning circuit places the output signal of the sensor into an appropriate form.
  • RF radio frequency
  • Many different signal conditioning circuits are known to those skilled in the art. Capacitance to frequency conversion, sigma delta or other analog to digital conversion techniques are all possible conditioning circuits that may be used in a preferred embodiment.
  • the signal transmission circuitry transmits the encoded signal from the signal conditioning circuitry for reception by an external reader. Magnetic telemetry is again used for this communication, as the transmission circuitry generates an alternating electromagnetic field that propagates to the reader. Either the same coil 9 is used for signal reception and for transmission, or alternately a second coil 21 is dedicated for transmission only.
  • the preferred embodiment has limited protrusion of volume into the blood stream, as both shape and size are factors in thrombogenesis.
  • Another shell may be overmolded or preformed to house the glass/silicon module, and the outer shell contains the necessary apparatus for anchoring the implant.
  • the outer shell may be formed with existing plastic injection technologies suitable for medical implantation.
  • a coating, preferably of silicone, parylene and/or polymers provides a non-thrombogenic exterior for the biologic environment.
  • the implant may be located in various places depending on the blood pressure measurement of interest. For chronic heart failure the end-diastolic pressure may be of most importance, and therefore the left chambers of the heart or immediately attaching vessels may be preferred locations. Because the number of implants is not practically limited by the technology, multiple locations for blood pressure and/or other physiologic parameter measurements are easily established, including all chambers of the heart, major arteries and appendages. In the preferred embodiment, embedding the module in an area that does not significantly impede blood flow can minimize the thrombogenic effect of flow turbulence caused by this volume.
  • the implant may be modified with anchoring methods found on devices already used for implantation.
  • Devices such as septal occluders, pacemaker leads, left atrial appendage occluders, etc. may be used as carriers for the current invention.
  • Pacemaker leads have a well-established history for implantation methods, and similar techniques are possible for the current invention.
  • a screw 13 or barb may be used to attach the implant to a heart or vessel wall.
  • a screw may be molded into the device shell 26 , and screwed into the ventricle wall so that the screw buries below the wall surface.
  • the package may have mesh 25 attached to the device to promote tissue growth and anchoring.
  • a second package option can be attached with a metal tine or barb placed with a catheter. These devices work well in trabeculated areas of the heart, and therefore are used often for implanting pacing leads in the right ventricle. Clips or expanding probes may also be used, both of which would penetrate the heart or vessel wall slightly.
  • Atrial septum defects a septal occluder
  • An umbrella structure 14 may be folded inside a catheter for delivery and then expanded for implantation.
  • the present invention may be anchored to the septum with similar techniques, as shown in FIG. 5 .
  • An important aspect of this preferred embodiment is that the majority of the implantable sensing device is located in the right side of the heart, with minimum protrusion in the left side of the heart. This embodiment will greatly reduce the thrombogenicity.
  • the readout 18 includes an inductor 19 for communicating with and powering the implant 17 via magnetic telemetry. Also included is signal reception 24 , signal processing 23 , and transmission circuitry 22 for data analysis and subsequent communication.
  • FIG. 3 illustrates the system diagram and the blocks of the reader. There are many techniques for construction of the reader coil and processing electronics known to those skilled in the art.
  • the reader may interface to a display, computer, or other data logging device 20 .
  • the described system could be augmented with various actuation functions.
  • the implant device would augmented with any of various actuators, including but not limited to: thermal generators; voltage or current sources, probes, or electrodes; drug delivery pumps, valves, or meters; microtools for localized surgical procedures; radiation-emitting sources; defibrillators; muscle stimulators; pacing stimulators.

Abstract

A system for monitoring blood pressure and other physiologic parameters is provided. The system is designed such that it can be delivered to the patient with ease and minimal invasion. The system contains at least one self contained implantable sensing device consisting of a sensor, an electrical circuit for signal conditioning and magnetic telemetry, a biocompatible outer surface and seal, an anchoring method, and an external readout device. The implant is small in size so that it may be delivered to the desired location and implanted using a catheter, although direct surgical implantation is also possible. The circuit, sensor, and antenna for telemetry are packaged together and sealed hermetically to the biologic environment. The larger readout unit remains outside the body but proximal to the implant for minimizing communication distance.

Description

    REFERENCE TO PREVIOUS APPLICATIONS
  • This is a division patent application of co-pending U.S. patent application Ser. No. 10/677,674.
  • FIELD OF THE INVENTION
  • This invention relates generally to medical devices monitoring blood pressure and other physiologic parameters.
  • BACKGROUND OF THE INVENTION
  • A number of different physiologic parameters are strong candidates for continuous monitoring, such as blood pressure or flow, cardiovascular pressure, intracranial pressure, intraocular pressure, glucose levels, etc. Wireless sensors in particular are highly desirable for biologic applications because the transcutaneous passage of wires (or other communication “tethers”) risks both infection to the patient and physical injury or device damage if the communication link experiences excessive pulling force.
  • A large number of proposed schemes for non-medical wireless communication rely on magnetic coupling between an electrical coil in an implanted device and a separate, external “readout” coil. One method of wireless communication well-known to those knowledgeable in the art is that of the LC tank resonator. A series-parallel connection of a capacitor and inductor has a specific resonant frequency ideally expressed as 1/√{square root over (LC)}, which can be measured from the impedance of the circuit. If one element of the inductor-capacitor pair varies with some physical parameter (e.g. pressure), while the other element remains at a known value, the physical parameter may be determined from the resonant frequency. For example, if the capacitor corresponds to a capacitive pressure sensor, the capacitance may be back-calculated from the resonant frequency. The sensed pressure may then be deduced from the capacitance by means of a calibrated pressure-capacitance transfer function.
  • The impedance of the LC tank may be measured directly or it may also be determined indirectly from the impedance of a separate readout coil that is magnetically coupled to the internal coil. The latter case is most useful for biologic applications in that the sensing device may be subcutaneously implanted, while the readout coil may be located external to the body, but in a location that allows magnetic coupling between the implant and readout coil. It is possible for the readout coil (or coils) to simultaneously excite the implant resonator and sense the impedance reflected back to the readout coil. Consequently, this architecture has the substantial advantage of requiring no internal power source, which greatly improves its prospects for long-term implantation (e.g. decades to a human lifetime).
  • Such devices have been proposed in various forms for many applications. Chubbuck (U.S. Pat. No. 4,026,276), Bullara (U.S. Pat. No. 4,127,110), and Dunphy (U.S. Pat. No. 3,958,558) disclose various devices initially intended for hydrocephalus applications (but also amenable to others) that use LC resonant circuits. The '276, '110, and '558 patents, although feasible, do not take advantage of recent advances in silicon (or similar) microfabrication technologies. Kensey (U.S. Pat. No. 6,015,386) discloses an implantable device for measuring blood pressure in a vessel of the wrist. This device must be “assembled” around the vessel being monitored such that it fully encompasses the vessel, which may not be feasible in many cases. In another application, Frenkel (U.S. Pat. No. 5,005,577) describes an implantable lens for monitoring intraocular pressure. Such a device would be advantageous for monitoring elevated eye pressures (as is usually the case for glaucoma patients); however, the requirement that the eye's crystalline lens be replaced will likely limit the general acceptance of this device.
  • In addition to the aforementioned applications that specify LC resonant circuits, other applications would also benefit greatly from such wireless sensing. Han, et al. (U.S. Pat. No. 6,268,161) describe a wireless implantable glucose (or other chemical) sensor that employs a pressure sensor as an intermediate transducer (in conjunction with a hydrogel) from the chemical into the electrical domain.
  • For example, the treatment of cardiovascular diseases such as Chronic Heart Failure (CHF) can be greatly improved through continuous and/or intermittent monitoring of various pressures and/or flows in the heart and associated vasculature. Porat (U.S. Pat. No. 6,277,078), Eigler (U.S. Pat. No. 6,328,699), and Carney (U.S. Pat. No. 5,368,040) each teach different modes of monitoring heart performance using wireless implantable sensors. In every case, however, what is described is a general scheme of monitoring the heart. The existence of a method to construct a sensor with sufficient size, long-term fidelity, stability, telemetry range, and biocompatibility is noticeably absent in each case, being instead simply assumed. Eigler, et al., come closest to describing a specific device structure although they disregard the baseline and sensitivity drift issues that must be addressed in a long-term implant. Applications for wireless sensors located in a stent (e.g., U.S. Pat. No. 6,053,873 by Govari) have also been taught, although little acknowledgment is made of the difficulty in fabricating a pressure sensor with telemetry means sufficiently small to incorporate into a stent.
  • Closed-loop drug delivery systems, such as that of Feingold (U.S. Pat. No. 4,871,351) have likewise been taught. As with others, Feingold overlooks the difficulty in fabricating sensors that meet the performance requirements needed for long-term implantation.
  • In nearly all of the aforementioned cases, the disclosed devices require a complex electromechanical assembly with many dissimilar materials, which will result in significant temperature- and aging-induced drift over time. Such assemblies may also be too large for many desirable applications, including intraocular pressure monitoring and/or pediatric applications. Finally, complex assembly processes will make such devices prohibitively expensive to manufacture for widespread use.
  • As an alternative to conventionally fabricated devices, microfabricated sensors have also been proposed. One such device is taught by Darrow (U.S. Pat. No. 6,201,980). Others are reported in the literature (see, e.g. Park, et al., Jpn. J. Appl. Phys., 37 (1998), pp. 7124-7128; Puers, et al., J. Micromech. Microeng. 10 (2000), pp. 124-129; Harpster et al., Proc. 14th IEEE Intl Conf. Microelectromech. Sys. (2001), pp. 553-557).
  • Past efforts to develop wireless sensors have typically been limited to implant-readout separation distances of 1-2 cm, rendering them impractical for implantation much below the cutaneous layer. This would eliminate from consideration applications such as heart ventricle pressure monitoring or intracranial pressure monitoring, which require separation distances in the range of 5-10 cm. In the present state-of-the-art, several factors have contributed to this limitation, including: 1) signal attenuation due to intervening tissue, 2) suboptimal design for magnetic coupling efficiency; and 3) high internal energy losses in the implanted device.
  • SUMMARY OF THE INVENTION
  • It is an object of this invention to provide a system for chronic monitoring of blood pressure and other physiological parameters.
  • It is also an object of this invention to provide a system including an implantable device for monitoring blood pressure and other physiologic parameters that is delivered to the patient with ease and minimal invasion.
  • It is also an object of this invention to provide a method for delivering an implantable device for monitoring blood pressure and other physiologic parameters that is delivered to the patient with ease and minimal invasion.
  • The above objects are achieved by providing at least a self contained implantable sensing device consisting of a sensor, an electrical circuit for signal conditioning and magnetic telemetry, a biocompatible outer surface and seal, an anchoring method, and an external reader device. The implant is small in size so that it may be delivered to the desired location and implanted using a catheter, although direct surgical implantation is also possible. The circuit, sensor, and antenna for telemetry are packaged together in a small volume and sealed hermetically to the biologic environment. The larger reader unit remains outside the body but proximal to the implant for minimizing communication distance.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a side view of a miniature sensor module according to a preferred embodiment of the present invention.
  • FIG. 2 is a top, side, and perspective view of a flexible substrate to rigid substrate self aligning connection illustrating a preferred arrangement of electrical leads within a substrate cavity.
  • FIG. 3 is a block diagram of a magnetic telemetry based physiologic monitoring system according to a preferred embodiment of the present invention.
  • FIG. 4 is a perspective view of a sensor implant incorporating a screw anchoring mechanism.
  • FIG. 5 is a side view of a sensor implanted in the atrial septum according to a preferred embodiment of the present invention.
  • DETAILED DESCRIPTION OF PREFERRED AND ALTERNATE EMBODIMENTS OF THE INVENTION
  • The following description of preferred embodiments and methods provides examples of the present invention. The embodiments discussed herein are merely exemplary in nature, and are not intended to limit the scope of the invention in any manner. Rather, the description of these preferred embodiments and methods serves to enable a person of ordinary skill in the relevant art to make, use and perform the present invention.
  • The preferred communication scheme for the present invention, shown in FIG. 3, is based on magnetic telemetry. Without an external reader 18 present, an implant 17 lays passive and without any internal means to power itself. When a pressure reading is desired, the reader 19 is brought into a suitable range to the implant 17. The reader 18 then creates an RF (Radio Frequency) magnetic field large enough to induce sufficient voltage across the implant coil 9. When such a sufficient voltage exists across the implant coil 9, the implant circuit 8 may rectify the alternating waveform to create a direct voltage, which analog and/or digital circuitry may use as a power supply. At this point the implant 17 can be considered alert and, in the preferred embodiment, also ready for commands from the reader 18.
  • Once the direct voltage in the implant 17 has been established for the circuit operation, a number of techniques may be used to convert the sensor output into a form suitable for transmission back to the reader 18. In the preferred embodiment, a capacitive pressure sensor 2 and sigma delta conversion or capacitance to frequency conversion of the sensor output may be easily used. Capacitive sensors are preferred due to the small power requirements for electronics when reading capacitance values. Many pressure sensors are based on piezoresistive effects and, while suitable for some applications, do suffer in this application due to the higher power levels needed for readout. Sigma delta converters are preferred due to the tolerance of noisy supply voltages and manufacturing variations.
  • As those skilled in magnetic telemetry are aware, a number of modulation schemes are available for transmitting data via magnetic coupling. The preferred schemes include but are not limited to amplitude modulation, frequency modulation, frequency shift keying, phase shift keying, and also spread spectrum techniques. The preferred modulation scheme may be determined by the specifications of an individual application, and is not intended to be limited under this invention.
  • In addition to the many available modulation techniques are the many technologies developed that allow the implant 17 to communicate back to the reader 18 the signal containing pressure information. It is understood that the reader 18 may transmit either a continuous level of RF power to supply the implant's needed energy, or it may pulse the power allowing temporary storage in a battery or capacitor device. Similarly, the implant 17 of FIG. 3 may signal back to the reader 18 at any interval in time, delayed or instantaneous, during reader RF transmission or alternately in the absence of reader transmission. The implant 17 may include a single coil antenna 9 for both reception and transmission, or it may include two antennas, one each for transmission 21 and reception 9.
  • The preferred embodiment of the invention is based on a small inner package, preferably of glass and silicon, that can be fit with a number of shell options for various implantation methods. The cross-section in FIG. 1 illustrates a glass and silicon package for the miniature implant 17 according to a preferred embodiment of the invention. As illustrated in FIG. 1, the implant 17 includes a substrate 1, a miniature sensor 2, and electronics 3 (both coil 9 and integrated circuit die 8 included in electronics). A secondary and optional substrate 4 may be used for attaching the various electronic components to each other and to sensor connections. An alternative preferred method is to use a cylindrical shaped package, made from silicon, glass, ceramic, metal, plastic, or any combination thereof which houses the coil and the electronic components. The miniature sensor 2 can either be fabricated separately and is attached to the cylindrical package or may be directly fabricated onto the substrate 1. Note that the shell may be a separately fabricated piece into which the sensor 2 is placed; or it may be directly fabricated on the sensor submodule (or some portion thereof); or it may be integral to the inner package, being only defined by a change in material.
  • The purpose of the shell is to simplify fabrication by allowing different processes, process flows, materials, and/or structures to be used for the subassembly (e.g. MEMS technologies) and the shell (e.g. machining and/or molding of plastics, glass, metals, rubbers, polymers, etc.) In some applications, the material of the sensor submodule may be compatible with the environment, in which case a shell is not required and the submodule becomes the completed sensor.
  • The miniature sensor 2 can be any suitable miniature sensor adapted to detect and/or monitor various physiological parameters. For example, the sensor 2 can comprise a pressure sensor, a temperature sensor, a flow sensor, a velocity sensor, or a sensor adapted to measure specific chemistries such as gas content (e.g., O2 and CO2) and glucose levels. Various specific examples of these types of miniature sensors are known to those skilled in the art, and any one or more of these suitable sensors can be utilized in the sensor module of the present invention. While the specific type of sensor(s) 2 chosen will depend on the application of the implantable system, the sensor(s) 2 should be of a sufficiently small size in order to facilitate placement within a catheter for delivery and implantation.
  • In the preferred embodiment of the implant 17 shown in FIG. 1, the bottom substrate 1 defines a cavity 6 in which the electronics 3 may be placed. With cubic geometry, the rigid substrate cavity walls enclose the electronics 3 on five of the six possible sides. Also in a preferred embodiment, at least part of the sensor 2 is disposed on the top side of the bottom substrate 1. Connections 16 to the sensor 2 may be made in a substrate recess 5 (recess is optional for increased clearance, and connection may alternately be co-planar with or above the plane of the substrate) adjoining the larger cavity 6, or through alternate lead transfer techniques in the substrate cavity 6.
  • A top substrate 7 is attached to the bottom substrate 1 to form a hermetic seal around the sensor and electronics. In a preferred embodiment, the physically interacting parts of the sensor are formed in the top substrate 7 and complete the sensor structure after subsequent processing steps after bonding. The two substrates 1 and 17 may be made of materials such as glass and silicon that are preferably anodically bonded together and provide excellent bond mechanical properties. Alternate methods of attachment include: fusion, frit, solder, laser welds, other welding, compression, thermal, thermal compression, eutectic, glue.
  • In a preferred arrangement, the electronic circuitry is connected together via a rigid or flexible substrate, which may be either the bottom substrate 1 or a separate substrate 4. The connection between the integrated circuit die 8 and substrate 1 or 4 is preferably made with flip-chip process to avoid the more fragile wire bonds. The circuit die 8 may include ASIC (Application Specific Integrated Circuits), capacitors, or diodes. The leads from the inductor coil 9 may fold over the substrate 4 or preformed for soldering to the substrate 4 with a preferably biocompatible solder such as gold-tin or silver-tin. The flexible substrate 4 may also extend to the connections for the sensor 2, where the connection may be made with a number of methods such as silver epoxy, laser welding, solder, or other.
  • Aligning the flexible substrate 4 to the bottom substrate recess 5 is shown in FIG. 2. A preferred structure to accommodate manufacturing tolerances matches a tapered recess 5 in the bottom substrate 1 to a wedge fixture 15 of the flex circuit 4, ensuring that electrical contacts 16 are properly aligned. As the wedge 15 is inserted into the recess 5, the electrical contacts 16 are forced to align themselves to avoid faulty connections. Furthermore, any variance in the width of the wedges 15 and recess 5 will be accommodated by a small variation in the final, lateral depth of insertion of the flex circuit 4.
  • FIG. 3 illustrates a block diagram for the electronics 3 according to the present invention. The electronic circuit may consist of a receiving inductor coil 9, rectification circuitry 10, signal conditioning circuitry 11, and signal transmission circuitry 12.
  • A large number of possible geometries and structures are available for receiver coil 9 and known to those skilled in the art. The coil conductor may be wound around a ferrite core to enhance magnetic properties, deposited on a flat rigid or flexible substrate, and formed into a long/skinny or short/wide cylindrical solenoid. The conductor is preferably made at least in part with a metal of high conductivity such as copper, silver, gold. The coil may alternately be fabricated on substrates 1, 4, or 8 (or any combination thereof) of FIG. 1. Methods of fabrication include sputtering, electroplating, lift-off, screen printing, and/or other suitable methods known to those skilled in the art.
  • The rectification circuitry 10 outputs a constant voltage level for the other electronics from an alternating voltage input. Efficient realizations of such circuitry are standard electronic techniques and may include full bridge diode rectifiers in the preferred embodiment. This rectification circuitry may include a capacitor for transient energy storage to reduce the noise ripple on the output supply voltage. This circuitry may be implemented on the same integrated circuit die with other electronics.
  • The signal conditioning circuit 11 processes an output signal from the sensor 2 and prepares it for transmission to an external receiving and/or analyzing device. For example, many pressure sensors output a capacitance signal that may be digitized for radio frequency (RF) transmission. Accordingly, the signal conditioning circuit places the output signal of the sensor into an appropriate form. Many different signal conditioning circuits are known to those skilled in the art. Capacitance to frequency conversion, sigma delta or other analog to digital conversion techniques are all possible conditioning circuits that may be used in a preferred embodiment.
  • The signal transmission circuitry transmits the encoded signal from the signal conditioning circuitry for reception by an external reader. Magnetic telemetry is again used for this communication, as the transmission circuitry generates an alternating electromagnetic field that propagates to the reader. Either the same coil 9 is used for signal reception and for transmission, or alternately a second coil 21 is dedicated for transmission only.
  • To limit the risk of thrombogenesis, the preferred embodiment has limited protrusion of volume into the blood stream, as both shape and size are factors in thrombogenesis. Another shell may be overmolded or preformed to house the glass/silicon module, and the outer shell contains the necessary apparatus for anchoring the implant. In a preferred embodiment, the outer shell may be formed with existing plastic injection technologies suitable for medical implantation. A coating, preferably of silicone, parylene and/or polymers provides a non-thrombogenic exterior for the biologic environment.
  • The implant may be located in various places depending on the blood pressure measurement of interest. For chronic heart failure the end-diastolic pressure may be of most importance, and therefore the left chambers of the heart or immediately attaching vessels may be preferred locations. Because the number of implants is not practically limited by the technology, multiple locations for blood pressure and/or other physiologic parameter measurements are easily established, including all chambers of the heart, major arteries and appendages. In the preferred embodiment, embedding the module in an area that does not significantly impede blood flow can minimize the thrombogenic effect of flow turbulence caused by this volume.
  • The implant may be modified with anchoring methods found on devices already used for implantation. Devices such as septal occluders, pacemaker leads, left atrial appendage occluders, etc. may be used as carriers for the current invention.
  • Pacemaker leads have a well-established history for implantation methods, and similar techniques are possible for the current invention. A screw 13 or barb may be used to attach the implant to a heart or vessel wall. In the first package option shown in FIG. 4, a screw may be molded into the device shell 26, and screwed into the ventricle wall so that the screw buries below the wall surface. In addition, the package may have mesh 25 attached to the device to promote tissue growth and anchoring.
  • A second package option can be attached with a metal tine or barb placed with a catheter. These devices work well in trabeculated areas of the heart, and therefore are used often for implanting pacing leads in the right ventricle. Clips or expanding probes may also be used, both of which would penetrate the heart or vessel wall slightly.
  • Devices have been made and approved by the FDA to occlude atrial septum defects (a septal occluder) and other vascular holes. An umbrella structure 14 may be folded inside a catheter for delivery and then expanded for implantation. In a preferred embodiment, the present invention may be anchored to the septum with similar techniques, as shown in FIG. 5. An important aspect of this preferred embodiment is that the majority of the implantable sensing device is located in the right side of the heart, with minimum protrusion in the left side of the heart. This embodiment will greatly reduce the thrombogenicity.
  • The readout 18 includes an inductor 19 for communicating with and powering the implant 17 via magnetic telemetry. Also included is signal reception 24, signal processing 23, and transmission circuitry 22 for data analysis and subsequent communication. FIG. 3 illustrates the system diagram and the blocks of the reader. There are many techniques for construction of the reader coil and processing electronics known to those skilled in the art. The reader may interface to a display, computer, or other data logging device 20.
  • Note that in addition to sensing physiologic parameters, the described system could be augmented with various actuation functions. In such case, the implant device would augmented with any of various actuators, including but not limited to: thermal generators; voltage or current sources, probes, or electrodes; drug delivery pumps, valves, or meters; microtools for localized surgical procedures; radiation-emitting sources; defibrillators; muscle stimulators; pacing stimulators.
  • The foregoing disclosure includes the best mode devised by the inventors for practicing the invention. It is apparent, however, that several variations in the apparatuses and methods of the present invention may be conceivable by one skilled in the art. Inasmuch as the foregoing disclosure is intended to enable one skilled in the pertinent art to practice the instant invention, it should not be construed to be limited thereby, but should be construed to include such aforementioned variations.

Claims (7)

1. A miniature implant for measuring physiologic parameters for medical applications, comprising:
Implantable self-contained sensor module for measuring physiologic parameters wherein the module:
senses physiologic parameters with a sensor;
receives operating power from a magnetic field with an inductor coil;
conditions a sensor signal;
transmits a conditioned sensor signal to an external signal detection system via magnetic telemetry;
outer shell to house sensor module fit with anchoring mechanism for implantation.
2. The miniature implant of claim 1 wherein the implant is delivered and implanted with a catheter.
3. The miniature implant of claim 1 wherein the anchoring mechanism passes through a septum wall and opens on either side of a septal wall, clamping the implant to the wall.
4. The miniature implant of claim 1 wherein the anchoring mechanism is a helical screw.
5. The miniature implant of claim 1 wherein the anchoring mechanism is a tine that expands and catches on a trabeculated area of the heart.
6. The implant of claim 1 wherein said module is used for applications including but not limited to one or more of the following
cardiovascular diseases,
congestive heart failure,
congenital heart diseases,
diseases related to intracranial pressure,
abdominal aortic aneurysm,
intraocular pressure for eye related diseases including but not limited to glaucoma,
urinary diseases,
gastrointestinal diseases.
7. The implant of claim 1 wherein the sensor measures one or more of the following
parameters
pressure,
temperature,
flow,
blood composition,
blood gas content,
chemical composition,
acceleration,
vibration.
US12/704,685 2002-10-03 2010-02-12 Wireless device and system for monitoring physiologic parameters Abandoned US20110046452A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/704,685 US20110046452A1 (en) 2002-10-03 2010-02-12 Wireless device and system for monitoring physiologic parameters

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US41553702P 2002-10-03 2002-10-03
US41553802P 2002-10-03 2002-10-03
US41640902P 2002-10-07 2002-10-07
US41640602P 2002-10-07 2002-10-07
US41640702P 2002-10-07 2002-10-07
US41640802P 2002-10-07 2002-10-07
US10/677,674 US7686762B1 (en) 2002-10-03 2003-10-02 Wireless device and system for monitoring physiologic parameters
US12/704,685 US20110046452A1 (en) 2002-10-03 2010-02-12 Wireless device and system for monitoring physiologic parameters

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/677,674 Division US7686762B1 (en) 2002-10-03 2003-10-02 Wireless device and system for monitoring physiologic parameters

Publications (1)

Publication Number Publication Date
US20110046452A1 true US20110046452A1 (en) 2011-02-24

Family

ID=57132902

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/677,674 Active - Reinstated 2026-12-16 US7686762B1 (en) 2002-10-03 2003-10-02 Wireless device and system for monitoring physiologic parameters
US12/399,131 Active 2029-08-21 US9498130B2 (en) 2002-10-03 2009-03-06 Wireless device and system for monitoring physiologic parameters
US12/704,685 Abandoned US20110046452A1 (en) 2002-10-03 2010-02-12 Wireless device and system for monitoring physiologic parameters

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/677,674 Active - Reinstated 2026-12-16 US7686762B1 (en) 2002-10-03 2003-10-02 Wireless device and system for monitoring physiologic parameters
US12/399,131 Active 2029-08-21 US9498130B2 (en) 2002-10-03 2009-03-06 Wireless device and system for monitoring physiologic parameters

Country Status (1)

Country Link
US (3) US7686762B1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2725969A1 (en) * 2011-06-30 2014-05-07 Endotronix, Inc. Implantable sensor enclosure with thin sidewalls
WO2014144070A1 (en) * 2013-03-15 2014-09-18 Hunter William L Stent monitoring assembly and method of use thereof
RU2613086C2 (en) * 2015-05-08 2017-03-15 Общество с ограниченной ответственностью "М-ЛАЙН" (ООО "М-ЛАЙН") Device for long-term remote invasive monitoring of state and critical changes of cardiovascular system for patients with comorbidity
US10022054B2 (en) 2011-06-08 2018-07-17 Integrated Sensing Systems, Inc. Implantable wireless sensor systems
CN108778108A (en) * 2016-03-23 2018-11-09 皇家飞利浦有限公司 Blood pressure monitor
US10206592B2 (en) 2012-09-14 2019-02-19 Endotronix, Inc. Pressure sensor, anchor, delivery system and method
US10226218B2 (en) 2011-06-30 2019-03-12 Endotronix, Inc. Pressure sensing implant
IT201800003693A1 (en) * 2018-03-16 2019-09-16 St Microelectronics Srl STRESS SENSOR, STRUCTURAL INTEGRITY MONITORING SYSTEM FOR CONSTRUCTION AND MANUFACTURING PROCESS OF A STRESS SENSOR
US10499855B2 (en) 2012-12-21 2019-12-10 Canary Medical Inc. Stent graft monitoring assembly and method of use thereof
US10524694B2 (en) 2014-06-25 2020-01-07 Canaray Medical Inc. Devices, systems and methods for using and monitoring tubes in body passageways
US10638955B2 (en) 2011-06-30 2020-05-05 Endotronix, Inc. Pressure sensing implant
US10687704B2 (en) 2009-12-30 2020-06-23 The University Of Kentucky Research Foundation System, device, and method for determination of intraocular pressure
US11103146B2 (en) 2005-06-21 2021-08-31 St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) Wireless sensor for measuring pressure
US11896365B2 (en) 2011-06-30 2024-02-13 Endotronix, Inc. MEMS device for an implant assembly

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050165317A1 (en) * 2003-11-04 2005-07-28 Turner Nicholas M. Medical devices
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
AU2006239221C1 (en) 2005-04-28 2012-08-16 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
WO2007028035A2 (en) 2005-09-01 2007-03-08 Proteus Biomedical, Inc. Implantable zero-wire communications system
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
KR101611240B1 (en) 2006-10-25 2016-04-11 프로테우스 디지털 헬스, 인코포레이티드 Controlled activation ingestible identifier
EP2069004A4 (en) 2006-11-20 2014-07-09 Proteus Digital Health Inc Active signal processing personal health signal receivers
EP3785599B1 (en) 2007-02-01 2022-08-03 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker systems
CA2676280C (en) 2007-02-14 2018-05-22 Proteus Biomedical, Inc. In-body power source having high surface area electrode
WO2008112578A1 (en) 2007-03-09 2008-09-18 Proteus Biomedical, Inc. In-body device having a deployable antenna
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US10003862B2 (en) 2007-03-15 2018-06-19 Endotronix, Inc. Wireless sensor reader
US8154389B2 (en) 2007-03-15 2012-04-10 Endotronix, Inc. Wireless sensor reader
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
WO2010100649A1 (en) 2009-03-04 2010-09-10 Sensible Medical Innovations Ltd. Methods and systems for monitoring intrabody tissues
WO2009031150A2 (en) * 2007-09-05 2009-03-12 Sensible Medical Innovations Ltd. Method and system for monitoring thoracic tissue fluid
PT2192946T (en) 2007-09-25 2022-11-17 Otsuka Pharma Co Ltd In-body device with virtual dipole signal amplification
US20090221885A1 (en) * 2008-02-25 2009-09-03 Cardiac Pacemakers, Inc. Optical Window Assembly for Implantable Medical Device
EP3827811A1 (en) 2008-03-05 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Multi-mode communication ingestible event markers and systems
WO2010005877A2 (en) 2008-07-08 2010-01-14 Proteus Biomedical, Inc. Ingestible event marker data framework
JP5715564B2 (en) 2008-08-13 2015-05-07 プロテウス デジタル ヘルス, インコーポレイテッド Ingestible device and method of producing the same
US10667715B2 (en) 2008-08-20 2020-06-02 Sensible Medical Innovations Ltd. Methods and devices of cardiac tissue monitoring and analysis
KR101192690B1 (en) 2008-11-13 2012-10-19 프로테우스 디지털 헬스, 인코포레이티드 Ingestible therapy activator system, therapeutic device and method
WO2010068818A2 (en) 2008-12-11 2010-06-17 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
TWI503101B (en) 2008-12-15 2015-10-11 Proteus Digital Health Inc Body-associated receiver and method
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
SG172846A1 (en) 2009-01-06 2011-08-29 Proteus Biomedical Inc Ingestion-related biofeedback and personalized medical therapy method and system
WO2010080764A2 (en) 2009-01-06 2010-07-15 Proteus Biomedical, Inc. Pharmaceutical dosages delivery system
US8072764B2 (en) * 2009-03-09 2011-12-06 Apple Inc. Multi-part substrate assemblies for low profile portable electronic devices
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
WO2010129288A2 (en) 2009-04-28 2010-11-11 Proteus Biomedical, Inc. Highly reliable ingestible event markers and methods for using the same
EP2432458A4 (en) 2009-05-12 2014-02-12 Proteus Digital Health Inc Ingestible event markers comprising an ingestible component
US8907682B2 (en) * 2009-07-30 2014-12-09 Sensible Medical Innovations Ltd. System and method for calibration of measurements of interacted EM signals in real time
EP2467707A4 (en) 2009-08-21 2014-12-17 Proteus Digital Health Inc Apparatus and method for measuring biochemical parameters
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
UA109424C2 (en) 2009-12-02 2015-08-25 PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS
US8715300B2 (en) 2009-12-05 2014-05-06 Integrated Sensing Systems, Inc. Delivery system, method, and anchor for medical implant placement
SG182825A1 (en) 2010-02-01 2012-09-27 Proteus Biomedical Inc Data gathering system
CA2795746C (en) 2010-04-07 2019-10-01 Timothy Robertson Miniature ingestible device
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
EP2642983A4 (en) 2010-11-22 2014-03-12 Proteus Digital Health Inc Ingestible device with pharmaceutical product
US8928671B2 (en) 2010-11-24 2015-01-06 Fujitsu Limited Recording and analyzing data on a 3D avatar
US20120130203A1 (en) * 2010-11-24 2012-05-24 Fujitsu Limited Inductively-Powered Ring-Based Sensor
US8602983B2 (en) 2010-12-20 2013-12-10 Covidien Lp Access assembly having undercut structure
US8641610B2 (en) 2010-12-20 2014-02-04 Covidien Lp Access assembly with translating lumens
US8696557B2 (en) 2010-12-21 2014-04-15 Covidien Lp Access assembly including inflatable seal member
US8868794B2 (en) 2010-12-27 2014-10-21 Medtronic, Inc. Application limitations for a medical communication module and host device
JP2014514032A (en) 2011-03-11 2014-06-19 プロテウス デジタル ヘルス, インコーポレイテッド Wearable personal body-related devices with various physical configurations
US9649113B2 (en) 2011-04-27 2017-05-16 Covidien Lp Device for monitoring physiological parameters in vivo
US20230371842A1 (en) * 2011-06-30 2023-11-23 Endotronix, Inc. Implantable sensor enclosure with thin sidewalls
US9011551B2 (en) 2011-07-11 2015-04-21 The Regents Of The University Of Michigan Multimodality left atrial appendage occlusion device
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2013011511A1 (en) 2011-07-18 2013-01-24 Mor Research Applications Ltd. A device for adjusting the intraocular pressure
IN2014MN00183A (en) 2011-07-21 2015-06-19 Proteus Digital Health Inc
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
MY182541A (en) 2012-07-23 2021-01-25 Proteus Digital Health Inc Techniques for manufacturing ingestible event markers comprising an ingestible component
CA2888871C (en) 2012-10-18 2016-08-09 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
JP2016508529A (en) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス, インコーポレイテッド Highly expandable polymer film and composition containing the same
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
JP6498177B2 (en) 2013-03-15 2019-04-10 プロテウス デジタル ヘルス, インコーポレイテッド Identity authentication system and method
JP5941240B2 (en) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス, インコーポレイテッド Metal detector device, system and method
EP2999419B1 (en) 2013-05-22 2020-12-23 Covidien LP Apparatus for controlling surgical instruments using a port assembly
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
RU2736776C2 (en) 2013-09-20 2020-11-20 Протеус Диджитал Хелс, Инк. Methods, devices and systems for receiving and decoding signals in the presence of noise using sections and deformation
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
WO2016022713A1 (en) * 2014-08-05 2016-02-11 Purvis Rick Telemetry arrangements for implantable devices
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10478067B2 (en) 2016-05-09 2019-11-19 Integrated Sensing Systems, Inc. Implantable sensing devices and anchoring methods therefor
CA3024891A1 (en) 2016-05-31 2017-12-07 Qura, Inc. Implantable intraocular pressure sensors and methods of use
EP3487393A4 (en) 2016-07-22 2020-01-15 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
CN109963499B (en) 2016-10-26 2022-02-25 大冢制药株式会社 Method for manufacturing capsules with ingestible event markers
AU2017371223B2 (en) 2016-12-09 2023-04-27 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
US11615257B2 (en) 2017-02-24 2023-03-28 Endotronix, Inc. Method for communicating with implant devices
EP3585252A1 (en) 2017-02-24 2020-01-01 Endotronix, Inc. Wireless sensor reader assembly
EP3612084A1 (en) 2017-04-20 2020-02-26 Endotronix, Inc. Anchoring system for a catheter delivered device
EP3630230A4 (en) 2017-05-21 2020-12-30 Oncodisc, Inc. Low profile implantable medication infusion port with electronic localization, physiologic monitoring, and data transfer
CN108968976B (en) 2017-05-31 2022-09-13 心脏起搏器股份公司 Implantable medical device with chemical sensor
EP3654835A1 (en) 2017-07-19 2020-05-27 Endotronix, Inc. Physiological monitoring system
CN109381195B (en) 2017-08-10 2023-01-10 心脏起搏器股份公司 Systems and methods including electrolyte sensor fusion
CN109419515B (en) 2017-08-23 2023-03-24 心脏起搏器股份公司 Implantable chemical sensor with staged activation
EP3479757A1 (en) 2017-11-07 2019-05-08 Integrated Sensing Systems, Inc. Implantable sensing devices and anchoring methods therefor
CN109864746B (en) 2017-12-01 2023-09-29 心脏起搏器股份公司 Multimode analyte sensor for medical devices
CN109864747B (en) 2017-12-05 2023-08-25 心脏起搏器股份公司 Multimode analyte sensor optoelectronic interface
US11291391B2 (en) * 2017-12-11 2022-04-05 Microoptx Inc. Implantable ocular glucose sensor devices and methods
KR101884226B1 (en) * 2017-12-29 2018-08-02 신종환 Bio-signal detection apparatus using bone graft substitute
BR112020024640A2 (en) 2018-06-03 2021-03-02 Olga Bokeriya systems, methods and devices for the treatment of bradyarrhythmias, tachyarrhythmias and heart failure
US11096582B2 (en) 2018-11-20 2021-08-24 Veris Health Inc. Vascular access devices, systems, and methods for monitoring patient health
JP2023502997A (en) 2019-11-19 2023-01-26 ゼンフロー, インコーポレイテッド Systems, devices and methods for accurate deployment and imaging of implants within the prostatic urethra
JP2023526673A (en) 2020-05-19 2023-06-22 コラヴィ メディカル,インコーポレーテッド Injectable hemodynamic monitoring device, system and method
US11883028B2 (en) 2021-09-08 2024-01-30 Covidien Lp Systems and methods for post-operative anastomotic leak detection

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3958558A (en) * 1974-09-16 1976-05-25 Huntington Institute Of Applied Medical Research Implantable pressure transducer
US4026276A (en) * 1976-04-05 1977-05-31 The Johns Hopkins University Intracranial pressure monitor
US4127110A (en) * 1976-05-24 1978-11-28 Huntington Institute Of Applied Medical Research Implantable pressure transducer
US4871351A (en) * 1984-09-28 1989-10-03 Vladimir Feingold Implantable medication infusion system
US5005577A (en) * 1988-08-23 1991-04-09 Frenkel Ronald E P Intraocular lens pressure monitoring device
US5368040A (en) * 1993-08-02 1994-11-29 Medtronic, Inc. Apparatus and method for determining a plurality of hemodynamic variables from a single, chroniclaly implanted absolute pressure sensor
US6015386A (en) * 1998-05-07 2000-01-18 Bpm Devices, Inc. System including an implantable device and methods of use for determining blood pressure and other blood parameters of a living being
US6053873A (en) * 1997-01-03 2000-04-25 Biosense, Inc. Pressure-sensing stent
US6201980B1 (en) * 1998-10-05 2001-03-13 The Regents Of The University Of California Implantable medical sensor system
US6268161B1 (en) * 1997-09-30 2001-07-31 M-Biotech, Inc. Biosensor
US6277078B1 (en) * 1999-11-19 2001-08-21 Remon Medical Technologies, Ltd. System and method for monitoring a parameter associated with the performance of a heart
US6328699B1 (en) * 2000-01-11 2001-12-11 Cedars-Sinai Medical Center Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure
US6409674B1 (en) * 1998-09-24 2002-06-25 Data Sciences International, Inc. Implantable sensor with wireless communication
US6970742B2 (en) * 2000-01-11 2005-11-29 Savacor, Inc. Method for detecting, diagnosing, and treating cardiovascular disease
US20070032734A1 (en) * 2002-10-03 2007-02-08 Integrated Sensing Systems, Inc. Method for monitoring a physiologic parameter of patients with congestive heart failure
US7211048B1 (en) * 2002-10-07 2007-05-01 Integrated Sensing Systems, Inc. System for monitoring conduit obstruction

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5067491A (en) * 1989-12-08 1991-11-26 Becton, Dickinson And Company Barrier coating on blood contacting devices
US5833603A (en) * 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
DE19638813C1 (en) * 1996-09-20 1998-03-05 Sican F & E Gmbh Sibet Measuring device for medical applications with an intracorporeally usable sensor element and method for its production
US6111520A (en) 1997-04-18 2000-08-29 Georgia Tech Research Corp. System and method for the wireless sensing of physical properties
US5967986A (en) * 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US6432050B1 (en) 1997-12-30 2002-08-13 Remon Medical Technologies Ltd. Implantable acoustic bio-sensing system and method
US6486588B2 (en) 1997-12-30 2002-11-26 Remon Medical Technologies Ltd Acoustic biosensor for monitoring physiological conditions in a body implantation site
US6475170B1 (en) 1997-12-30 2002-11-05 Remon Medical Technologies Ltd Acoustic biosensor for monitoring physiological conditions in a body implantation site
US6278379B1 (en) 1998-04-02 2001-08-21 Georgia Tech Research Corporation System, method, and sensors for sensing physical properties
US6589180B2 (en) * 2001-06-20 2003-07-08 Bae Systems Information And Electronic Systems Integration, Inc Acoustical array with multilayer substrate integrated circuits
US7147604B1 (en) * 2002-08-07 2006-12-12 Cardiomems, Inc. High Q factor sensor

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3958558A (en) * 1974-09-16 1976-05-25 Huntington Institute Of Applied Medical Research Implantable pressure transducer
US4026276A (en) * 1976-04-05 1977-05-31 The Johns Hopkins University Intracranial pressure monitor
US4127110A (en) * 1976-05-24 1978-11-28 Huntington Institute Of Applied Medical Research Implantable pressure transducer
US4871351A (en) * 1984-09-28 1989-10-03 Vladimir Feingold Implantable medication infusion system
US5005577A (en) * 1988-08-23 1991-04-09 Frenkel Ronald E P Intraocular lens pressure monitoring device
US5368040A (en) * 1993-08-02 1994-11-29 Medtronic, Inc. Apparatus and method for determining a plurality of hemodynamic variables from a single, chroniclaly implanted absolute pressure sensor
US6053873A (en) * 1997-01-03 2000-04-25 Biosense, Inc. Pressure-sensing stent
US6268161B1 (en) * 1997-09-30 2001-07-31 M-Biotech, Inc. Biosensor
US6015386A (en) * 1998-05-07 2000-01-18 Bpm Devices, Inc. System including an implantable device and methods of use for determining blood pressure and other blood parameters of a living being
US6409674B1 (en) * 1998-09-24 2002-06-25 Data Sciences International, Inc. Implantable sensor with wireless communication
US6201980B1 (en) * 1998-10-05 2001-03-13 The Regents Of The University Of California Implantable medical sensor system
US6277078B1 (en) * 1999-11-19 2001-08-21 Remon Medical Technologies, Ltd. System and method for monitoring a parameter associated with the performance of a heart
US6328699B1 (en) * 2000-01-11 2001-12-11 Cedars-Sinai Medical Center Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure
US6970742B2 (en) * 2000-01-11 2005-11-29 Savacor, Inc. Method for detecting, diagnosing, and treating cardiovascular disease
US20070032734A1 (en) * 2002-10-03 2007-02-08 Integrated Sensing Systems, Inc. Method for monitoring a physiologic parameter of patients with congestive heart failure
US7211048B1 (en) * 2002-10-07 2007-05-01 Integrated Sensing Systems, Inc. System for monitoring conduit obstruction

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11684276B2 (en) 2005-06-21 2023-06-27 Tc1, Llc Implantable wireless pressure sensor
US11179048B2 (en) 2005-06-21 2021-11-23 St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) System for deploying an implant assembly in a vessel
US11103147B2 (en) 2005-06-21 2021-08-31 St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) Method and system for determining a lumen pressure
US11103146B2 (en) 2005-06-21 2021-08-31 St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) Wireless sensor for measuring pressure
US11890082B2 (en) 2005-06-21 2024-02-06 Tc1 Llc System and method for calculating a lumen pressure utilizing sensor calibration parameters
US10687704B2 (en) 2009-12-30 2020-06-23 The University Of Kentucky Research Foundation System, device, and method for determination of intraocular pressure
US10022054B2 (en) 2011-06-08 2018-07-17 Integrated Sensing Systems, Inc. Implantable wireless sensor systems
US10433764B2 (en) 2011-06-30 2019-10-08 Endotronix, Inc. Implantable sensor enclosure with thin sidewalls
US10226218B2 (en) 2011-06-30 2019-03-12 Endotronix, Inc. Pressure sensing implant
EP3345536A1 (en) * 2011-06-30 2018-07-11 Endotronix, Inc. Implantable sensor enclosure with thin sidewalls
US11547320B2 (en) 2011-06-30 2023-01-10 Endotronix, Inc. Implantable sensor enclosure with thin sidewalls
JP2017192733A (en) * 2011-06-30 2017-10-26 エンドトロニックス インコーポレイテッド Wireless circuitry
CN103857325A (en) * 2011-06-30 2014-06-11 内电子有限公司 Implantable sensor enclosure with thin sidewalls
US9867552B2 (en) 2011-06-30 2018-01-16 Endotronix, Inc. Implantable sensor enclosure with thin sidewalls
AU2012275126B2 (en) * 2011-06-30 2017-04-13 Endotronix, Inc. Implantable sensor enclosure with thin sidewalls
US11707230B2 (en) 2011-06-30 2023-07-25 Endotronix, Inc. Pressure sensing implant
EP2725969A1 (en) * 2011-06-30 2014-05-07 Endotronix, Inc. Implantable sensor enclosure with thin sidewalls
US11589773B2 (en) 2011-06-30 2023-02-28 Endotronix, Inc. MEMS device for an implant assembly
US10638955B2 (en) 2011-06-30 2020-05-05 Endotronix, Inc. Pressure sensing implant
EP2725969A4 (en) * 2011-06-30 2015-02-18 Endotronix Inc Implantable sensor enclosure with thin sidewalls
US11896365B2 (en) 2011-06-30 2024-02-13 Endotronix, Inc. MEMS device for an implant assembly
JP2014523320A (en) * 2011-06-30 2014-09-11 エンドトロニックス インコーポレイテッド Implantable sensor enclosure with thin sidewalls
US10206592B2 (en) 2012-09-14 2019-02-19 Endotronix, Inc. Pressure sensor, anchor, delivery system and method
US10499855B2 (en) 2012-12-21 2019-12-10 Canary Medical Inc. Stent graft monitoring assembly and method of use thereof
US11445978B2 (en) 2012-12-21 2022-09-20 Canary Medical Switzerland Ag Stent graft monitoring assembly and method of use thereof
WO2014144070A1 (en) * 2013-03-15 2014-09-18 Hunter William L Stent monitoring assembly and method of use thereof
US11389079B2 (en) 2014-06-25 2022-07-19 Canary Medical Inc. Devices, systems and methods for using and monitoring tubes in body passageways
US10524694B2 (en) 2014-06-25 2020-01-07 Canaray Medical Inc. Devices, systems and methods for using and monitoring tubes in body passageways
US11911141B2 (en) 2014-06-25 2024-02-27 Canary Medical Switzerland Ag Devices, systems and methods for using and monitoring tubes in body passageways
RU2613086C2 (en) * 2015-05-08 2017-03-15 Общество с ограниченной ответственностью "М-ЛАЙН" (ООО "М-ЛАЙН") Device for long-term remote invasive monitoring of state and critical changes of cardiovascular system for patients with comorbidity
CN108778108A (en) * 2016-03-23 2018-11-09 皇家飞利浦有限公司 Blood pressure monitor
US11237077B2 (en) 2018-03-16 2022-02-01 Stmicroelectronics S.R.L. Stress sensor, structural health monitoring system for constructions and process for manufacturing a stress sensor
IT201800003693A1 (en) * 2018-03-16 2019-09-16 St Microelectronics Srl STRESS SENSOR, STRUCTURAL INTEGRITY MONITORING SYSTEM FOR CONSTRUCTION AND MANUFACTURING PROCESS OF A STRESS SENSOR
US11898943B2 (en) 2018-03-16 2024-02-13 Stmicroelectronics S.R.L. Stress sensor, structural health monitoring system for constructions and process for manufacturing a stress sensor

Also Published As

Publication number Publication date
US7686762B1 (en) 2010-03-30
US20090182206A1 (en) 2009-07-16
US9498130B2 (en) 2016-11-22

Similar Documents

Publication Publication Date Title
US7686762B1 (en) Wireless device and system for monitoring physiologic parameters
US7615010B1 (en) System for monitoring the physiologic parameters of patients with congestive heart failure
US7211048B1 (en) System for monitoring conduit obstruction
US8512252B2 (en) Delivery method and system for monitoring cardiovascular pressures
US11033192B2 (en) Wireless sensor for measuring pressure
US6926670B2 (en) Wireless MEMS capacitive sensor for physiologic parameter measurement
JP3149957B2 (en) Implantable capacitive pressure and temperature sensors
EP2139385B1 (en) System for monitoring a physiological parameter within an internal organ of a living body
US7621036B2 (en) Method of manufacturing implantable wireless sensor for in vivo pressure measurement
US20070282210A1 (en) Implantable wireless sensor for in vivo pressure measurement and continuous output determination
US20090024042A1 (en) Method and system for monitoring ventricular function of a heart
US20040133092A1 (en) Wireless system for measuring distension in flexible tubes
US20080077016A1 (en) Monitoring system having implantable inductive sensor
US20080281212A1 (en) Transseptal monitoring device
WO2007002225A2 (en) Implantable wireless sensor for in vivo pressure measurement
CN113747835A (en) Occluder with self-powered sensor
US8231538B2 (en) Perivascular pressure sensor and sensing system
AU2012247061B2 (en) Implantable wireless sensor for in vivo pressure measurement
AU2014200072A1 (en) Implantable wireless sensor for in vivo pressure measurement and continuous output determination
Najafi Matthew Z. Straayer, Ann Arbor, MI wo wooi. 122.

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION